Abstract
Determining the concentration and size of lipoprotein complexes is very important due to their role in cardiovascular diseases and metabolic disorders. However, standard methods for lipoprotein fractionation are manual and time consuming and cannot be used as standard diagnostic tools. Because different subclasses of lipoproteins have different radii and, hence, different diffusion velocities, we propose a fast and reliable method that uses 2D diffusion-edited 1H NMR spectroscopy to acquire a set of 2D spectra of plasma samples, followed by a surface fitting algorithm based on Lorentzian functions to estimate the sizes and the relative proportions of different lipoprotein subclasses. We were able to demonstrate that the derived sizes and positions related to the Lorentzian functions follow an exponential relationship for normolipidaemic and dislipaemic samples with coefficients of determination (r 2) of 0.85 and 0.81, respectively. Moreover, we found a linear relationship between the width and size of the Lorentzian functions for normolipidaemic samples (r 2 = 0.88) while for dislipaemic samples this relation was nonlinear (r 2 = 0.62). Dividing our samples set into four different lipoprotein profiles (normal lipid values, low HDL/LDL ratio, high triglycerides values and both risk factors) and using principal component analysis (PCA) followed by multivariate analysis of variance (MANOVA), our method was able to statistically discriminate between those groups, with p-values of 0.0016, 0.0006, <1e−4 and 0.0035, respectively. These parameters are characteristic and indicative of different lipoprotein profiles and can be used to distinguish between normolipidaemic, hypercholesterolaemic, hypertriglyceridaemic and chylomicronaemic profiles.
Similar content being viewed by others
References
AlaKorpela, M. (1995) H-1 NMR spectroscopy of human blood plasma. Progress in Nuclear Magnetic Resonance Spectroscopy, 27, 475–554.
Ala-Korpela, M. (2008). Critical evaluation of H-1 NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics. Clinical Chemistry and Laboratory Medicine, 46, 27–42.
AlaKorpela, M., Hiltunen, Y., & Bell, J. D. (1995). Quantification of biomedical NMR data using artificial neural network analysis: Lipoprotein lipid profiles from H-1 NMR data of human plasma. NMR in Biomedicine, 8, 235–244.
Antalek, B. (2002). Using pulsed gradient spin echo NMR for chemical mixture analysis: How to obtain optimum results. Concepts in Magnetic Resonance, 14, 225–258.
Bachorik, P. S., & Ross, J. W. (1995). National-cholesterol-education-program recommendations for measurement of low-density-lipoprotein cholesterol—executive summary. Clinical Chemistry, 41, 1414–1420.
Bathen, T. F., Krane, J., Engan, T., Bjerve, K. S., & Axelson, D. (2000). Quantification of plasma lipids and apolipoproteins by use of proton NMR spectroscopy, multivariate and neural network analysis. NMR in Biomedicine, 13, 271–288.
Beckwith-Hall, B. M., Thompson, N. A., Nicholson, J. K., Lindon, J. C., & Holmes, E. (2003). A metabonomic investigation of hepatotoxicity using diffusion-edited H-1 NMR spectroscopy of blood serum. Analyst, 128, 814–818.
Cantor C. R., & Schimmel, P. R. (1980). Biophysical chemistry, part ii: Techniques for the study of biological structure and function. San Francisco: W.H. Freeman.
Chapman, M. J., Goldstein, S., Lagrange, D., & Laplaud, P. M. (1981). A density gradient ultra-centrifugal procedure for the isolation of the major lipoprotein classes from human-serum. Journal of Lipid Research, 22, 339–358.
Duell, P. B., Illingworth, D. R., & Connor, W. E. (2001). Endocrinology and metabolism (4th ed.). McGraw-Hill: New York.
Dyrby, M., Petersen, M., Whittaker, A. K., Lambert, L., Norgaard, L., Bro, R., et al. (2005). Analysis of lipoproteins using 2D diffusion-edited NMR spectroscopy and multi-way chemometrics. Analytica Chimica Acta, 531, 209–216.
Festa, A., Williams, K., Hanley, A. J. G., Otvos, J. D., Goff, D. C., Wagenknecht, L. E., et al. (2005). Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the insulin resistance atherosclerosis study. Circulation, 111, 3465–3472.
Fossel, E. T., Carr, J. M., & McDonagh, J. (1986). Detection of malignant-tumors—water-suppressed proton nuclear-magnetic-resonance spectroscopy of plasma. New England Journal of Medicine, 315, 1369–1376.
Freedman, D. S., Otvos, J. D., Jeyarajah, E. J., Barboriak, J. J., Anderson, A. J., & Walker, J. A. (1998). Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 18, 1046–1053.
Friedewa, W. T, Fredrick, D. S., & Levy, R. I. (1972). Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clinical Chemistry, 18, 499–502.
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. A. (1982). Separation and quantitation of subclasses of human-plasma high-density lipoproteins by a simple precipitation procedure. Journal of Lipid Research, 23, 1206–1223.
Gofman, J. W., Lindgren, F. T., & Elliott, H. (1949). Ultracentrifugal studies of lipoproteins of human serum. Journal of Biological Chemistry, 179, 973–979.
Jerschow, A., & Muller, N. (1997). Suppression of convection artifacts in stimulated-echo diffusion experiments. Double-stimulated-echo experiments. Journal of Magnetic Resonance, 125, 372–375.
Jeyarajah, E. J., Cromwell, W. C., & Otvos, J. D. (2006). Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clinics in Laboratory Medicine, 26, 847–870.
Jialal, I., Hirany, S. V., Devaraj, S., & Sherwood, T. A. (1995). Comparison of an immunoprecipitation method for direct measurement of LDL-cholesterol with beta-quantification (ultracentrifugation). American Journal of Clinical Pathology, 104, 76–81.
Johnson, C. S. (1999). Diffusion ordered nuclear magnetic resonance spectroscopy: Principles and applications. Progress in Nuclear Magnetic Resonance Spectroscopy, 34, 203–256.
Kesmarky, G., Kenyeres, P., Rabai, M., & Toth, K. (2008). Plasma viscosity: A forgotten variable. Clin. Hemorheol. Microcirc., 39, 243–246.
Kremer, W., Kalbitzer, H. R., & Huber, F. (2008). US Patent Application 2008/0038829 A1.
Kumpula, L. S., Makela, S. M., Makinen, V. P., Karjalainen, A., Liinamaa, J. M., Kaski, K., et al. (2010). Characterization of metabolic interrelationships and in silico phenotyping of lipoprotein particles using self-organizing maps. Journal of Lipid Research, 51, 431–439.
Lamarche, B., & Lewis, G. F. (1998). Atherosclerosis prevention for the next decade: Risk assessment beyond low density lipoprotein cholesterol. Canadian Journal of Cardiology, 14, 841–851.
Lamarche, B., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despres, J. P. (1997). Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men—prospective results from the Quebec cardiovascular study. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 1098–1105.
Liu, M. L., Tang, H. R., Nicholson, J. K., & Lindon, J. C. (2002). Use of H-1 NMR-determined diffusion coefficients to characterize lipoprotein fractions in human blood plasma. Magnetic Resonance in Chemistry, 40, S83–S88.
Lounila, J., Alakorpela, M., Jokisaari, J., Savolainen, M. J., & Kesaniemi, Y. A. (1994). Effects of orientational order and particle-size on the NMR line positions of lipoproteins. Physical Review Letters, 72, 4049–4052.
Nicholson, J. K., Foxall, P. J. D., Spraul, M., Farrant, R. D., & Lindon, J. C. (1995). 750-Mhz H-1 and H-1-C-13 NMR-spectroscopy of human blood-plasma. Analytical Chemistry, 67, 793–811.
Noble, R. P. (1968). Electrophoretic separation of plasma lipoproteins in agarose gel. Journal of Lipid Research, 9, 693–700.
Otvos, J. D., Jeyarajah, E. J., Bennett, D. W., & Krauss, R. M. (1992). Development of a proton nuclear-magnetic-resonance spectroscopic method for determining plasma-lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clinical Chemistry, 38, 1632–1638.
Otvos, J. D., Jeyarajah, E. J., Hayes, L. W., Freedman, D. S., Janjan, N. A., & Anderson, T. (1991). Relationships between the proton nuclear-magnetic-resonance properties of plasma-lipoproteins and cancer. Clinical Chemistry, 37, 369–376.
Petersen, M., Dyrby, M., Toubro, S., Engelsen, S. B., Norgaard, L., Pedersen, H. T., et al. (2005). Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models. Clinical Chemistry, 51, 1457–1461.
Roheim, P. S., & Asztalos, B. F. (1995). Clinical-significance of lipoprotein size and risk for coronary atherosclerosis. Clinical Chemistry, 41, 147–152.
Rosenson, R. S., Shott, S., & Tangney, C. C. (2002). Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: Triglycerides and blood viscosity. Atherosclerosis, 161, 433–439.
Savorani, F., Kristensen, M., Larsen, F. H., Astrup, A., & Engelsen, S. B. (2010). High throughput prediction of chylomicron triglycerides in human plasma by nuclear magnetic resonance and chemometrics. Nutrition & Metabolism, 7, 8.
Schaefer, E. J., Anderson, D. W., Brewer, H. B., Levy, R. I., Danner, R. N., & Blackwelder, W. C. (1978). Plasma-triglycerides in regulation of HDL-cholesterol levels. Lancet, 2, 391–393.
Schectman, G., Patsches, M., & Sasse, E. A. (1996). Variability in cholesterol measurements: Comparison of calculated and direct LDL cholesterol determinations. Clinical Chemistry, 42, 732–737.
Schumaker, V. N., & Puppione, D. L. (1986). Sequential flotation ultracentrifugation. Methods in Enzymology, 128, 155–170.
Seplowitz, A. H., Chien, S., & Smith, F. R. (1981). Effects of lipoproteins on plasma viscosity. Atherosclerosis, 38, 89–95.
Stein, E. A., & Myers, G. L. (1995). National-cholesterol-education-program recommendations for triglyceride measurement—executive summary. Clinical Chemistry, 41, 1421–1426.
Suna, T., Salminen, A., Soininen, P., Laatikainen, R., Ingman, P., Makela, S., et al. (2007). H-1 NMR metabonomics of plasma lipoprotein subclasses: Elucidation of metabolic clustering by self-organising maps. NMR in Biomedicine, 20, 658–672.
Thompson, G. R. (1998). Angiographic evidence for the role of triglyceride-rich lipoproteins in progression of coronary artery disease. European Heart Journal, 19, H31–H36.
Tyrrell, H. J. V., & Harris, K. R. (1984). Diffusion in liquids: A theoretical and experimental study. London: Butterworths.
Vehtari, A., Makinen, V. P., Soininen, P., Ingman, P., Makela, S. M., Savolainen, M. J., et al. (2007). A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in H-1 NMR metabonomic data. Bmc Bioinformatics, 8(suppl 2).
Warnick, G. R., & Wood, P. D. (1995). National-cholesterol-education-program recommendations for measurement of high-density-lipoprotein cholesterol—executive summary. Clinical Chemistry, 41, 1427–1433.
Wu, P. S. C., & Otting, G. (2005). Rapid pulse length determination in high-resolution NMR. Journal of Magnetic Resonance, 176, 115–119.
Acknowledgments
We acknowledge CIBER de Diabetes y Enfermedades Metabólicas, an initiative of ISCIII (Ministerio de Ciencia e Innovación) for partially funding this work, as well as FIS (project PI 081409). We acknowledge Dr. Gareth Morris for fruitful discussions about the diffusion experiments.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Mallol, R., Rodríguez, M.A., Heras, M. et al. Surface fitting of 2D diffusion-edited 1H NMR spectroscopy data for the characterisation of human plasma lipoproteins. Metabolomics 7, 572–582 (2011). https://doi.org/10.1007/s11306-011-0273-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11306-011-0273-8